Any current/future new fundraising through debt or equity?

Current total debt increased to around ₹475 crores from ₹275-300 crores in the previous period. Peak anticipated debt is expected to be over ₹500 crores as per management guidance. Debt repayment is planned to start in FY26, not before. No specific mention of any new fundraising through equity in the disclosed call. The company has highlighted capital expenditure for capacity expansion (Greenfield project at Pakhajan) with no mention of fresh equity raise; likely funded through existing or planned debt. Management did not indicate immediate plans for additional debt beyond the anticipated peak

Any current/future capex/capital investment/strategic investment?

Greenfield project at Pakhajan is underway to more than double Yasho Industries' capacity. Trial run for the Pakhajan facility is planned post-Diwali, with production expected to start early FY25. The Pakhajan facility primarily focuses on industrial segment products. Incorporated a wholly-owned subsidiary in the United States to expand market reach and directly engage with customers, aiming for long-term growth and higher margins. The new US subsidiary will help reach more end users and reduce dependence on distributors. Capacity expansion is a key part of the growth strategy with expectation

Future growth expectations in sales/revenue/volumes?

The new Greenfield project at Pakhajan will more than double capacity, expected to start production in early FY25 with a trial run post-Diwali. Pakhajan facility (17,500 MT capacity) is expected to generate revenue of INR 500-600 crores, while the Vapi facility (12,500 MT capacity) targets INR 700-750 crores. Phase 1 capacity utilization at Pakhajan is expected to reach around 50% in FY25. Market for new products (A, B, C, D) shows potential, with targeted revenues up to INR 3,000 crores for product A & B combined, though company aims to capture only up to 20-25% market share to avoid overexpo

Future growth expectations in earnings/operating earnings/profits/EPS?

The company expects gradual ramp-up of the new Pakhajan facility starting Q1 FY25, targeting about 50% utilization in FY25. Vapi facility (12,500 MT capacity) is expected to generate ₹700-750 crores revenue with normalized gross margins of 38%-40% and EBITDA margins of 18%-19%. Pakhajan facility (17,500 MT capacity) is anticipated to contribute ₹500-600 crores revenue post FY25, producing bulk volume products with slightly lower realizations per ton. Margins are currently subdued due to high-cost inventory and buyer's market; however, improvement is expected from Q4 FY24 onwards, though margin

Current/ Expected Orderbook/ Pending Orders?

The company has seen some spark in inquiries and orders in Europe; however, the order pipeline there is getting empty, indicating cautious demand. In the USA, demand is described as very good and robust across all segments. To compensate for challenges in Europe, Yasho Industries is expanding its footprint into the Asian, Middle East, and Latin American markets. There is a mention of software commitments from customers for phase 1 capacity at Pakhajan. The ramp-up for phase 1 capacity is expected to reach about 50% utilization in FY25, depending on customer approvals and audits. Trial runs for

IN US

Sale is live|00:00:00left today

Yasho Industries LtdQ3 FY23Chemicals & Petrochemicals

Yasho Industries Ltd Q3 FY23 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹2,868P/E: 113.4Market Cap: ₹2.0K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 2

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→The new Greenfield project at Pakhajan will more than double capacity, expected to start production in early FY25 with a trial run post-Diwali.
→Pakhajan facility (17,500 MT capacity) is expected to generate revenue of INR 500-600 crores, while the Vapi facility (12,500 MT capacity) targets INR 700-750 crores.
→Phase 1 capacity utilization at Pakhajan is expected to reach around 50% in FY25.
→Market for new products (A, B, C, D) shows potential, with targeted revenues up to INR 3,000 crores for product A & B combined, though company aims to capture only up to 20-25% market share to avoid overexposure.
→Demand in the US market remains strong; Europe demand is uncertain but compensated by expansions into Asia, Middle East, and Latin America.
→Overall market growth for key products expected between 3-5%.
→The company aims for steady volume growth with better utilization and product mix improvements.

Margin guidance

Category 2

→The company expects gradual ramp-up of the new Pakhajan facility starting Q1 FY25, targeting about 50% utilization in FY25.
→Vapi facility (12,500 MT capacity) is expected to generate ₹700-750 crores revenue with normalized gross margins of 38%-40% and EBITDA margins of 18%-19%.
→Pakhajan facility (17,500 MT capacity) is anticipated to contribute ₹500-600 crores revenue post FY25, producing bulk volume products with slightly lower realizations per ton.
→Margins are currently subdued due to high-cost inventory and buyer's market; however, improvement is expected from Q4 FY24 onwards, though margins may not fully recover to previous highs soon.
→The company targets approximately 20%-25% market share in new product categories, contributing significantly to growth but without aiming for market dominance.
→Expansion into US, Asian, Middle Eastern, and Latin American markets intends to diversify demand and support robust growth, with the US market showing very good demand.

3 more insights locked — sign up free to unlock

Fundraise plans

→Current total debt increased to around ₹475 crores from ₹275-300 crores in the previous period.
→Peak anticipated debt is expected to be over ₹500 crores as per management guidance.
→Debt repayment is planned to start in FY26, not before.
→No specific mention of any new fundraising through equity in the disclosed call.
→The company has highlighted capital expenditure for capacity expansion (Greenfield project at Pakhajan) with no mention of fresh equity raise; likely funded through existing or planned debt.
→Management did not indicate immediate plans for additional debt beyond the anticipated peak.

Order book

→The company has seen some spark in inquiries and orders in Europe; however, the order pipeline there is getting empty, indicating cautious demand.
→In the USA, demand is described as very good and robust across all segments.
→To compensate for challenges in Europe, Yasho Industries is expanding its footprint into the Asian, Middle East, and Latin American markets.
→There is a mention of software commitments from customers for phase 1 capacity at Pakhajan.
→The ramp-up for phase 1 capacity is expected to reach about 50% utilization in FY25, depending on customer approvals and audits.
→Trial runs for the new Pakhajan facility are expected post-Diwali, targeting gradual capacity utilization growth.

Capex plans

Yes

→Greenfield project at Pakhajan is underway to more than double Yasho Industries' capacity.
→Trial run for the Pakhajan facility is planned post-Diwali, with production expected to start early FY25.
→The Pakhajan facility primarily focuses on industrial segment products.
→Incorporated a wholly-owned subsidiary in the United States to expand market reach and directly engage with customers, aiming for long-term growth and higher margins.
→The new US subsidiary will help reach more end users and reduce dependence on distributors.
→Capacity expansion is a key part of the growth strategy with expectations of substantial value creation for stakeholders.
→No mention of other specific capital or strategic investments in the discussion.

How does Yasho Industries Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

1Yasho Industries Ltd

Rev 3Mar 2

See full Chemicals & Petrochemicals sector rankings

Want more stocks like Yasho Industries Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio